tiprankstipranks
Neumora Therapeutics, Inc. (NMRA)
NASDAQ:NMRA
US Market

Neumora Therapeutics, Inc. (NMRA) Cash flow

Compare
272 Followers

Neumora Therapeutics, Inc. Cash Flow

NMRA's free cash flow for Q3 2024 was $-32.71M. For the 2024 fiscal year, NMRA's free cash flow was decreased by $-47.99M and operating cash flow was $-33.48M. See a summary of the company’s cash flow.
Cash Flow
Dec 23Dec 22Dec 21Dec 20
Operating Cash Flow
$ -163.28M$ -114.90M$ -75.42M$ -26.76M
Investing Cash Flow
$ 64.39M$ -168.01M$ -817.00K$ -11.24M
Financing Cash Flow
$ 231.94M$ 115.74M$ 293.51M$ 230.10M
End Cash Position
$ 375.25M$ 242.21M$ 409.37M$ 192.10M
Free Cash Flow
$ -163.40M$ -115.41M$ -76.24M$ -28.06M
Currency in USD

Neumora Therapeutics, Inc. Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis